Additionally, the quality and impact of our scientific research was well recognised this quarter with data for AstraZeneca medicines featuring in an unprecedented five Presidential Plenary sessions at ...

Under the leadership of Pam Cheng, the company’s chief sustainability officer, Breztri may soon be released in a new package ...

Wuxi International Life-Science Innovation Campus signed a strategic cooperation agreement with the Hong Kong Centre for ...

The pharmaceutical giant raised its full-year guidance after third-quarter revenue and core earnings per share topped ...

AstraZeneca now expects 2024 revenue and core earnings per share to grow by a high-teens percentage, from a previous forecast ...

EU mid-market update: Trump trade train in full steam ahead mode; Germany dials in election for Feb 23rd, while its ZEW index ...

The pharmaceutical giant expects overall sales and core earnings per share to rise by a high-teens percentage at constant ...

By Maggie Fick and Yadarisa Shabong (Reuters) -Drugmaker AstraZeneca lifted its annual sales and profit forecast for the ...

AstraZeneca plans to invest a whopping $3.5 billion to expand its R&D and manufacturing operations in the US by 2026 as part ...

LONDON — AstraZeneca said Tuesday it has had to resubmit a closely watched medicine for U.S. approval in a different form of ...

The boss of AstraZeneca has said the group takes the probe in China that saw the detention of its president in the country ...

AstraZeneca’s results were helped by resilient demand for its cancer and rare diseases medicines, after third-quarter results ...